Results 71 to 80 of about 4,273 (136)
New developments in the management of Waldenström macroglobulinemia
Jithma P Abeykoon,1 Uday Yanamandra,2 Prashant Kapoor1,3 1Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA; 2Department of Hematology and Stem Cell Transplant, Army Hospital (Research & Referral), Delhi, India; 3Division of Hematology,
Abeykoon JP, Yanamandra U, Kapoor P
doaj
Ibrutinib-Induced Pancreatitis in Patients with Waldenstrom Macroglobulinemia
Nurhilal Büyükkurt, Barış Soydaş
doaj +1 more source
Refining prognostic tools in Waldenström macroglobulinemia. [PDF]
Lionel AC, Thomas SK.
europepmc +1 more source
Waldenström Macroglobulinemia Presenting With Hepatic Lesions: Case Report and Literature Review. [PDF]
Sternbach N +3 more
europepmc +1 more source
POD24 is a novel determinant of prognosis in patients with Waldenström macroglobulinemia. [PDF]
Zanwar S +28 more
europepmc +1 more source
Ibrutinib response in a patient with refractory mixed essential cryoglobulinemia
Haya Jamali +5 more
doaj +1 more source
Waldenström macroglobulinemia-associated renal AL amyloidosis: a case report and literature review. [PDF]
Zhang J +7 more
europepmc +1 more source
An Atypical Presentation of Ecthyma Gangrenosum in a Patient With Waldenström Macroglobulinemia. [PDF]
Eggert-Cichocki SR +3 more
europepmc +1 more source

